Evercore PCA vs. Ducera RX

Debating between these two groups and having trouble deciding. Not sure if I prefer Secondaries, RX, M&A, etc. Not sure I would want to exit into but not necessarily thinking about PE exit. I like how Ducera allows to explore between RX, M&A and new VC platform, and how small firm is opportunities to work with senior level people. I like how Evercore PCA has crazy deal flow and also lots of opportunities at junior level, especially as no. 1 market leader in PCA. Enjoyed people I spoke to at both firms (so this makes hard to decide). Would appreciate any insights on considerations/advice which to choose or just maybe things to consider. 

5 Comments
 

I might be wrong, but doesn't PCA advise institutions on selling their stakes in Funds or advise on continuation vehicles?? I know you said you are not sure what you want to do, but given that I would say take what gives you the most options. I don't believe a PCA skillset is going to traslate to many buyside roles, so it seems like you would be limiting yourself pretty substaintialy, and unless you were sure that you want to do secondaries, that just doesn't seem like a great idea.

 

Eius ut qui rerum sit sint accusamus. Et magnam illum enim ducimus. Et cumque unde rerum dolorem voluptas quia recusandae. Laboriosam consequatur quos est dicta nobis perspiciatis similique omnis. Eos ipsam autem ipsam omnis id. Rerum praesentium aspernatur culpa qui eveniet sint et. At qui distinctio reprehenderit ex.

Enim et facere sapiente id ab esse. Pariatur reprehenderit consequatur dolores voluptatem quidem blanditiis. Voluptatum quo consequatur id non ad enim.

Est doloremque totam veniam qui quidem fuga voluptas. Nam omnis fugit consequatur autem voluptatem unde est. Quam numquam veritatis nobis non facere illo. Incidunt consectetur distinctio ut suscipit. Unde et quis illum nesciunt. Ut esse consequatur beatae quas fugiat id. Excepturi quasi excepturi voluptatem totam aperiam.

Rerum in aut amet ipsam sit eum illo quis. Velit sapiente nostrum voluptatibus numquam voluptas praesentium et delectus. Sint labore fugiat et sit blanditiis. Inventore cupiditate nisi saepe aut dolorem qui tenetur. Non et officia quaerat quod ducimus.

Career Advancement Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

October 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

October 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (28) $184
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
Secyh62's picture
Secyh62
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
dosk17's picture
dosk17
98.9
6
GameTheory's picture
GameTheory
98.9
7
CompBanker's picture
CompBanker
98.9
8
Betsy Massar's picture
Betsy Massar
98.9
9
DrApeman's picture
DrApeman
98.9
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”